FDA Draft Guidance Would Set In Stone Case For Quality Voluntary Improvement Program
Executive Summary
The draft document from the US agency looks to officially recognize a program aimed at advancing quality in medical devices and their manufacturing.
You may also be interested in...
FDA, MDIC Eye Technology Clearinghouse For Advanced Manufacturing
The US FDA is teaming up with the Medical Device Innovation Consortium to establish the clearinghouse, which would nudge medtech companies to adopt novel approaches that could take their manufacturing operations to a higher level.
Global Medtech Guidance Tracker: May 2022
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Forty-two documents have been posted on the tracker since its last update.
FDA Puts Finishing Touches On Draft Guidance To Set Case For Quality VIP Program In Stone
The goal of the guidance is to make the Case for Quality Voluntary Improvement Program, or CfQ VIP, “more official” at the US FDA, an agency official says. CfQ VIP aims to elevate product, manufacturing and process quality at medical device firms.